RTI Surgical, Inc. (RTIX) EPS Estimated At $0.02

April 16, 2018 - By Migdalia James

Investors sentiment increased to 1.35 in 2017 Q4. Its up 0.24, from 1.11 in 2017Q3. It increased, as 9 investors sold RTI Surgical, Inc. shares while 28 reduced holdings. 20 funds opened positions while 30 raised stakes. 42.10 million shares or 1.07% more from 41.65 million shares in 2017Q3 were reported.
Spark Invest Mgmt Ltd Liability Company has 0.03% invested in RTI Surgical, Inc. (NASDAQ:RTIX) for 119,342 shares. Brandywine Global Management Ltd Liability Co owns 23,200 shares for 0% of their portfolio. 86,883 are owned by California State Teachers Retirement Sys. Principal Fincl Gp invested in 0% or 10,540 shares. Prtn Limited Liability Company accumulated 0.01% or 48,800 shares. 93,162 are owned by Fmr Ltd Liability. Wedge Capital Mgmt L L P Nc stated it has 0.01% of its portfolio in RTI Surgical, Inc. (NASDAQ:RTIX). Wells Fargo Company Mn holds 0% or 91,008 shares in its portfolio. 50,342 were accumulated by Virtu Financial Ltd Liability Corp. Blackrock Inc invested in 0% or 4.91M shares. First Quadrant Ltd Partnership Ca has 0% invested in RTI Surgical, Inc. (NASDAQ:RTIX) for 6,318 shares. Amer reported 36,813 shares. Ajo Limited Partnership holds 711,247 shares. Schwab Charles Invest Management holds 0% or 108,300 shares in its portfolio. Northern Tru accumulated 672,004 shares or 0% of the stock.

Analysts expect RTI Surgical, Inc. (NASDAQ:RTIX) to report $0.02 EPS on April, 26.RTIX’s profit would be $1.23M giving it 59.69 P/E if the $0.02 EPS is correct. After having $0.03 EPS previously, RTI Surgical, Inc.’s analysts see -33.33 % EPS growth. The stock increased 1.60% or $0.075 during the last trading session, reaching $4.775. About 23,087 shares traded. RTI Surgical, Inc. (NASDAQ:RTIX) has risen 21.33% since April 16, 2017 and is uptrending. It has outperformed by 9.78% the S&P500.

RTI Surgical, Inc., together with its subsidiaries, designs, develops, makes, and distributes orthopedic and other surgical implants for use in various surgical procedures worldwide. The company has market cap of $294.77 million. The firm provides natural tissue implants, as well as metal and synthetic implants for the treatment of spinal and other orthopedic disorders. It has a 119.38 P/E ratio. It processes donated human musculoskeletal and other tissues, including bone, cartilage, tendons, ligaments, fascia lata, pericardium, sclera, cornea, and dermal tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

RTI Surgical, Inc. (NASDAQ:RTIX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.